Address: C76, Balewadi, Pune, Maharashtra

Global Heparin Anticoagulant Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Heparin Anticoagulant Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Heparin Anticoagulant Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Heparin Anticoagulant Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 03 Jan 2021
  • Report ID: HLT 0071
  • Pages:168
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Global Heparin Anticoagulant Market is anticipated to rise at a value CAGR of 1.7 % over 2019-2028. According to a study published by Insure Insights on the Global Heparin Anticoagulant Market. Heparin is an anticoagulant it acts by preventing clotting in the blood caused by certain medical conditions or medical procedures. It is also used before surgery in treating Cardiac disorders, it is used in the treatment of heart attacks and unstable angina. It is given either by the IV route f subcutaneous route. Favorable government initiatives for better treatment have fueled the market further.

Top Driver: The high rate of occurrence of Cardiovascular disorders have boosted the market

The rise in the incidences of Cardiac disorders has triggered the demand of the market; for instance, the Centre for Disease Control and Prevention has estimated that Coronary heart disease has caused the death of 365,914 people in the year 2017. The rise in the number of accidents and surgeries worldwide and an increase in the awareness regarding the use of heparin for anticoagulant effect, and an increase in the geriatric population have boosted the overall market

Low Molecular Weight Heparin has dominated growth in the Global Heparin Anticoagulant Market

Based on the Type, 3D Heparin Anticoagulant segment has held the highest segmental growth. As they efficiently prevent blood clots in the treatment of venous thromboembolism and also aids in the treatment of myocardial infarction. Low Molecular weight heparin does not need the monitoring of anticoagulation, and have a lower incidence of heparin-induced thrombocytopenia.

In terms of the Route of Administration, subcutaneous route segment has held the largest growth in the market as it is more preferred owing to ease of administration, and anticoagulants are required in small amounts, and due to need for the reduced duration of treatment. Based on the Application, coronary artery disease segment, has held to most significant growth owing to the rise in the cases CAD, lifestyle habits like smoking and consumption of alcohol has further triggered the growth.

 

North America dominated the regional market with the increase in the incidence of Cardiovascular disorders

The rise in the incidences of cardiovascular disorders like atrial fibrillation, Coronary artery disease has significantly fueled the growth of North America. The availability of sophisticated healthcare infrastructure, the rise in healthcare expenditure have further attributed to the regional growth of the market. The rise in the sports activities in the region and a considerable rise in the injuries related to it have fueled the growth opportunities for the region. Furthermore, the  increase in patient awareness have boosted the overall regional revenue

Product launches, Innovations, Strategic Collaborations, Mergers, and Acquisition, are the major strategies of the competitors

The Players of the Global Heparin Anticoagulant Market is fragmented.   The key competitors of the Global Heparin Anticoagulant Market are GlaxoSmithKline plc; Pfizer, Inc; Leo Pharma A/S; Sanofi; Dr. Reddy’s Laboratories Ltd.; Aspen Holdings; B. Braun Medical Inc.; Fresenius SE & Co. KGaA; Teva Pharmaceutical Industries Ltd.; and Baxter.

GlaxoSmithKline plc: GlaxoSmithKline plc, is one of the key competitors of the Global Heparin Anticoagulant Market. In January 2019 GlaxoSmithKline plc had announced the acquisition of TESARO, they are an oncology based company. This acquisition was made by GlaxoSmithKline to strengthen its product portfolio with oncology drugs. The deal of acquisition was made for USD 5.1 billion

Baxter:  Baxter is a popular competitor in the Global Heparin Anticoagulant Market. In December 2019, Baxter had announced the acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi; The deal of acquisition was made for USD 350 million. This acquisition was made by Baxter to expand its product portfolio. 

Scope of the Report

By Type

  • Low Molecular Weight Heparin
  • Ultra-low Molecular Weight Heparin
  • Unfractionated Heparin

By Route of Administration

  • Intravenous
  • Subcutaneous

By Application

  • Venous Thromboembolism
  • Atrial Fibrillation
  • Coronary Artery Disease
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1          Overview And Scope

1.1            Market Vision

1.1.1        Market Definition

1.1.2        Market Scope

1.2            Market Segmentation

Chapter 2          Our Research Practice

2.1            Our Research Methodology

2.2            Data Triangulation

2.3            Data Sources

2.4            Assumptions for the study

2.5            Approach Adopted

Chapter 3          Executive Summary

3.1            Market Snapshot

3.2            Regional Snapshot

3.3            Segment Summary

Chapter 4          Covid-19 Impact Analysis

4.1            Overview

4.2            Prevalence analysis

4.3            Key Factor Impact Analysis

Chapter 5          Global Sleep Apnea Devices Market Forces

5.1            What’s Driving the Market

5.2            Porter’s Five Forces Analysis

5.2.1        Power of Suppliers

5.2.2        Threats From New Entrants

5.2.3        Power of Buyer

5.2.4        Threat From Substitute Product

5.2.5        Degree of Competition

Chapter 6          Global Sleep Apnea Devices Market -Industry Snapshots

6.1            Overview

6.1.1        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

6.2            Market Overview

6.2.1        Drivers Analysis

6.2.2        Restraint/Challenges analysis

6.2.3        Opportunity Analysis

6.3            Supply Chain/Value Chain Analysis

6.4            Market SWOT Analysis

Chapter 7          Global Sleep Apnea Devices Market Analysis, by Diagnostic Devices

7.1            Overview

7.2            Key Findings for Sleep Apnea Devices Market- By Diagnostic Devices

7.2.1        Sleep Apnea Devices Market- Pulse oximeters

7.2.2        Sleep Apnea Devices Market- Actigraphy devices

7.2.3        Sleep Apnea Devices Market- Polysomnography Devices

Chapter 8          Global Sleep Apnea Devices Market Analysis, by Therapeutic Devices

8.1            Overview

8.2            Key Findings for Sleep Apnea Devices Market- By Therapeutic Devices

8.2.1        Sleep Apnea Devices Market- Oxygen Devices

8.2.2        Sleep Apnea Devices Market- Positive Airways Pressure Devices

8.2.3        Sleep Apnea Devices Market- Oral Appliances

8.2.4        Sleep Apnea Devices Market- Others

Chapter 9          Sleep Apnea Devices Market Analysis by Region

9.1            Key Findings for Sleep Apnea Devices Market- By region

9.2            Overview

9.2.1        Global Sleep Apnea Devices Market Analysis, By Diagnostic Devices, 2019 – 2028

9.2.2        Global Sleep Apnea Devices Market Analysis, By Therapeutic Devices, 2019 – 2028

9.3            Sleep Apnea Devices Market – North America

9.3.1        Overview

9.3.2        U.S.

9.3.3        Canada

9.3.4        Mexico

9.3.5        North America Market, By Diagnostic Devices

9.3.6        North America Market, By Therapeutic Devices

9.4            Sleep Apnea Devices Market – Europe

9.4.1        Overview

9.4.2        Germany

9.4.3        United Kingdom

9.4.4        France

9.4.5        Italy

9.4.6        Rest Of Europe

9.4.7        Europe Market, By Diagnostic Devices

9.4.8        Europe Market, By Therapeutic Devices

9.5            Sleep Apnea Devices Market – Asia Pacific

9.5.1        Overview

9.5.2        China

9.5.3        Japan

9.5.4        India

9.5.5        Rest of APAC

9.5.6        Asia Pacific Market, By Diagnostic Devices

9.5.7        Asia Pacific Market, By Therapeutic Devices

9.6            Sleep Apnea Devices Market – SAMEA

9.6.1        Overview

9.6.2        Middle East & Africa (MEA)

9.6.3        South America

9.6.4        Rest Of World

9.6.5        South America, Middle East and Africa Market, By Diagnostic Devices

9.6.6        South America, Middle East and Africa Market, By Therapeutic Devices

Chapter 10      Market Competition Analysis

10.1          Market Share/Positioning Analysis

10.1.1      Market Positioning of Key Vendors, 2019

10.1.2      Key Strategies Adopted by the Leading Players

10.1.3      Recent Developments

Chapter 11      Company Profiles- Snapshot

11.1          Curative Medical Inc

11.1.1      Business Fundamentals

11.1.2      Financial Snapshots

11.1.3      Product Portfolio

11.1.4      Recent Developments

11.2          Philips Respironics

11.3          ResMed

11.4          Fisher & Paykel Healthcare

11.5          Cadwell Laboratories

11.6          Invacare Corporation

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 12      Appendix

List of Figures

 

FIG. 1          Global Sleep Apnea Devices: Market Segmentation

FIG. 2          Global Sleep Apnea Devices Market: Research Methodology

FIG. 3          Top-Down and Bottom Up Approach

FIG. 4          Market Snapshot

FIG. 5          Porter’s Five Forces Analysis

FIG. 6          Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 7          Supply Chain/Value Chain Analysis

FIG. 8          Global Sleep Apnea Devices Market Value Contribution, By Diagnostic Devices, 2019 & 2026 (%)

FIG. 9          Global Sleep Apnea Devices Market Value Contribution, By Therapeutic Devices, 2019 & 2026 (%)

FIG. 10        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 11        North America Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 12        Sleep Apnea Devices Market Segment 1 – North America

FIG. 13        Sleep Apnea Devices Market Segment 2 – North America

FIG. 14        Sleep Apnea Devices U.S. outlook, 2019 & 2026

FIG. 15        Sleep Apnea Devices Canada outlook, 2019 & 2026

FIG. 16        Sleep Apnea Devices Mexico outlook, 2019 & 2026

FIG. 17        Europe Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 18        Sleep Apnea Devices Market Segment 1 – Europe

FIG. 19        Sleep Apnea Devices Market Segment 2 – Europe

FIG. 20        Sleep Apnea Devices Germany outlook, 2019 & 2026

FIG. 21        Sleep Apnea Devices United Kingdom outlook, 2019 & 2026

FIG. 22        Sleep Apnea Devices France outlook, 2019 & 2026

FIG. 23        Sleep Apnea Devices Italy outlook, 2019 & 2026

FIG. 24        Sleep Apnea Devices Rest Of Europe outlook, 2019 & 2026

FIG. 25        Asia Pacific Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 26        Sleep Apnea Devices Market Segment 1 – Asia Pacific

FIG. 27        Sleep Apnea Devices Market Segment 2 – Asia Pacific

FIG. 28        Sleep Apnea Devices China outlook, 2019 & 2026

FIG. 29        Sleep Apnea Devices Japan outlook, 2019 & 2026

FIG. 30        Sleep Apnea Devices India outlook, 2019 & 2026

FIG. 31        Sleep Apnea Devices Rest of APAC outlook, 2019 & 2026

FIG. 32        SAMEA Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 33        Sleep Apnea Devices Market Segment 1 – SAMEA

FIG. 34        Sleep Apnea Devices Market Segment 2 – SAMEA

FIG. 35        Sleep Apnea Devices Middle East & Africa (MEA) outlook, 2019 & 2026

FIG. 36        Sleep Apnea Devices South America outlook, 2019 & 2026

FIG. 37        Sleep Apnea Devices Rest Of World outlook, 2019 & 2026

 

List of Tables

 

TABLE 1      Sleep Apnea Devices market by Diagnostic Devices 1, 2019 – 2028 (USD Million)

TABLE 2      Sleep Apnea Devices market by Diagnostic Devices 2, 2019 – 2028 (USD Million)

TABLE 3      Sleep Apnea Devices market by Diagnostic Devices 3, 2019 – 2028 (USD Million)

TABLE 4      Sleep Apnea Devices market by Therapeutic Devices 1, 2019 – 2028 (USD Million)

TABLE 5      Sleep Apnea Devices market by Therapeutic Devices 2, 2019 – 2028 (USD Million)

TABLE 6      Sleep Apnea Devices market by Therapeutic Devices 3, 2019 – 2028 (USD Million)

TABLE 7      Sleep Apnea Devices market by Therapeutic Devices 4, 2019 – 2028 (USD Million)

TABLE 8      Global Sleep Apnea Devices Market Value, By Diagnostic Devices, 2019 – 2028 (US$ Bn)

TABLE 9      Global Sleep Apnea Devices Market Value, By Therapeutic Devices, 2019 – 2028 (US$ Bn)

TABLE 10   Sleep Apnea Devices Market Analysis by North America (USD Million), 2019 – 2028

TABLE 11   U.S. Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 12   U.S. Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 13   U.S. Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 14   Canada Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 15   Canada Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 16   Canada Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 17   Mexico Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 18   Mexico Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 19   Mexico Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 20   Sleep Apnea Devices Market Analysis by Europe (USD Million), 2019 – 2028

TABLE 21   Germany Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 22   Germany Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 23   Germany Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 24   United Kingdom Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 25   United Kingdom Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 26   United Kingdom Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 27   France Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 28   France Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 29   France Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 30   Italy Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 31   Italy Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 32   Italy Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 33   Rest Of Europe Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 34   Rest Of Europe Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 35   Rest Of Europe Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 36   Sleep Apnea Devices Market Analysis by Asia Pacific (USD Million), 2019 – 2028

TABLE 37   China Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 38   China Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 39   China Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 40   Japan Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 41   Japan Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 42   Japan Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 43   India Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 44   India Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 45   India Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 46   Rest of APAC Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 47   Rest of APAC Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 48   Rest of APAC Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 49   Sleep Apnea Devices Market Analysis by SAMEA (USD Million), 2019 – 2028

TABLE 50   Middle East & Africa (MEA) Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 51   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 52   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 53   South America Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 54   South America Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 55   South America Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 56   Rest Of World Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 57   Rest Of World Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 58   Rest Of World Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

Request for Sample

Please fill out the form to receive sample pages of the report